
Current Price | $96.25 | Mkt Cap | $191.9B |
---|---|---|---|
Open | $96.19 | P/E Ratio | 29.43 |
Prev. Close | $96.25 | Div. (Yield) | $3.50 (3.6%) |
Daily Range | $95.34 - $96.49 | Volume | 3,607,519 |
52-Wk Range | $74.09 - $105.56 | Avg. Daily Vol. | 2,167,694 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
Current Price | $96.25 | Mkt Cap | $191.9B |
---|---|---|---|
Open | $96.19 | P/E Ratio | 29.43 |
Prev. Close | $96.25 | Div. (Yield) | $3.50 (3.6%) |
Daily Range | $95.34 - $96.49 | Volume | 3,607,519 |
52-Wk Range | $74.09 - $105.56 | Avg. Daily Vol. | 2,167,694 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
Under-priced stock with a strong portfolio and increased revenue.
Recs
Novartis has numerous fast-growing drugs, which is why analysts are expecting 8% annual earnings growth over the next five years. At just 13 times this year's earnings, Novartis is reasonably priced. That's why I expect the stock will outperform the S&P 500 in the next 5-10 years.
Recs
With this epidemic and once the find a cure they are for sure to take off
Find the members with the highest scoring picks in NVS.
wcwhiner (27.52) Score: +153.69
The Score Leader is the player with the highest score across all their picks in NVS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Bankwatcher1 | 25.81 | 10/7/2008 |
![]() |
NS | $37.26 | +158.32% | +305.31% | +146.99 | 0 Comment | |
Spelunkin | 27.23 | 11/2/2009 |
![]() |
5Y | $37.64 | +155.73% | +300.79% | +145.05 | 0 Comment | |
PurePwnage | 97.05 | 11/27/2009 |
![]() |
5Y | $39.92 | +141.11% | +285.00% | +143.89 | 0 Comment | |
39272x0 | 31.36 | 12/2/2009 |
![]() |
5Y | $40.94 | +135.12% | +275.04% | +139.92 | 0 Comment | |
kaChingkaChing | 37.53 | 12/2/2009 |
![]() |
3W | $40.94 | +135.12% | +275.04% | +139.92 | 0 Comment | |
TrackDuality | < 20 | 11/6/2009 |
![]() |
5Y | $38.04 | +153.00% | +292.75% | +139.76 | 0 Comment | |
DiamondDawg | 89.10 | 11/25/2009 |
![]() |
5Y | $40.57 | +137.22% | +275.41% | +138.18 | 0 Comment | |
39272x4 | 23.51 | 11/10/2009 |
![]() |
5Y | $38.92 | +147.28% | +281.79% | +134.51 | 0 Comment | |
wcwhiner | 27.52 | 4/28/2009 |
![]() |
NS | $26.99 | +256.67% | +390.44% | +133.77 | 0 Comment | |
BridgeTech | < 20 | 5/29/2009 |
![]() |
3Y | $29.04 | +231.40% | +361.29% | +129.89 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.